کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8719805 | 1589095 | 2017 | 18 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence
ترجمه فارسی عنوان
درمان های روان برای آنژیوتانسین تبدیل آنژیوادم ناشی از مهار کننده آنزیم: یک بررسی سیستماتیک شواهد کنونی
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
طب اورژانس
چکیده انگلیسی
While findings of decreased time to symptom resolution or a cessation in symptom progression have been reported with each of these therapies, additional data showing clinically relevant implications, such as reduced intensive care unit length of stay or avoidance of mechanical ventilation, are warranted, especially when taking cost into consideration. FFP has limited evidence demonstrating a benefit for treatment of ACEI-induced angioedema without consistent dosing strategies. However, given its wide availability and low potential for adverse reactions, FFP therapy may be reasonable. Of the novel agents traditionally used for hereditary angioedema, icatibant has the highest level of evidence and has been reported to be successful in limiting the progression of angioedema.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: The Journal of Emergency Medicine - Volume 53, Issue 5, November 2017, Pages 662-679
Journal: The Journal of Emergency Medicine - Volume 53, Issue 5, November 2017, Pages 662-679
نویسندگان
Heidi M. PharmD, BCPS, Bryant B. PharmD, BCPS, Jessica V. PharmD, BCPS, Megan A. PharmD, BCPS, BCCCP,